Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Red light therapy is emerging as a non-invasive way to boost energy and ease mobility challenges in MS by supporting mitochondrial function, reducing inflammation, and improving blood flow. However, device choice, treatment frequency, target areas, safety precautions, and integration with exercise and prescribed therapies can all influence outcomes.
For practical tips, research highlights, safety guidelines, and guidance on next steps for your healthcare journey, see below.
Multiple sclerosis (MS) often brings persistent fatigue and mobility challenges that can impact daily life. Red light therapy (RLT) is emerging as a non-invasive approach to help manage these symptoms. This article reviews how RLT works, what the research says, and practical tips for using red light therapy for MS fatigue and mobility.
Fatigue is one of the most common and disabling symptoms of MS. It can be:
Mobility problems often include:
Traditional approaches—medications, exercise programs, energy-conservation strategies—help many people but don't fully resolve fatigue or mobility limits. That's where complementary therapies like red light therapy come in.
Red light therapy (RLT), also called low-level light therapy (LLLT) or photobiomodulation, uses specific red and near-infrared wavelengths (600–1,000 nm) to stimulate cellular processes. It's delivered by:
RLT is painless, non-thermal (doesn't heat tissues), and typically used in sessions lasting 5–20 minutes, 2–5 times per week.
Researchers believe RLT works through several key mechanisms:
Mitochondrial Support
Improved Blood Flow
Reduced Inflammation
Neuroprotection and Repair
While the exact effects in MS require more large-scale trials, early studies and anecdotal reports suggest that RLT can positively impact fatigue and mobility.
These findings are promising but not definitive. RLT should be viewed as a complementary tool, not a replacement for standard MS therapies.
Red light therapy is generally safe, with few reports of side effects. Keep in mind:
Choose the Right Device
Frequency and Duration
Target Areas
Combine With Exercise and Stretching
Track Your Progress
If you're experiencing new or changing symptoms, Ubie's free AI-powered Multiple Sclerosis (MS) symptom checker can help you better understand your condition and identify areas where additional support may be beneficial before your next appointment.
Everyone responds differently. Some people notice quick shifts, others more gradual changes. Patience and consistency are key.
Red light therapy is low risk, but always check with your healthcare provider if you experience:
If you ever experience life-threatening or serious symptoms, call emergency services or go to your nearest hospital immediately.
Red light therapy offers a promising, non-invasive way to support energy levels and improve mobility in people with MS. By stimulating cellular energy, reducing inflammation, and enhancing blood flow, RLT can become a valuable part of a comprehensive MS management plan. Always:
If you have concerns about your symptoms or treatment plan, don't hesitate—speak to a doctor and explore ways to tailor your approach for the best possible quality of life.
(References)
* Salehpour F, Mahmoodi F, Rasta J. The effect of photobiomodulation on fatigue, cognitive function, and quality of life in patients with multiple sclerosis: a systematic review and meta-analysis. Lasers Med Sci. 2023 Sep;38(1):210. doi: 10.1007/s10103-023-03822-0. Epub 2023 Jul 19. PMID: 37466549.
* Blanco-Alvarez EE, Rivas-Vazquez AR, Sanchez-Manso JC, et al. Transcranial photobiomodulation for cognitive function and fatigue in multiple sclerosis: a randomized controlled trial. J Neurol. 2022 Sep;269(9):4930-4942. doi: 10.1007/s00415-022-11105-z. Epub 2022 Apr 20. PMID: 35441838.
* Ramezani A, Zarkesh M, Abareshi F, et al. Low-level laser therapy for fatigue in multiple sclerosis: a systematic review. J Lasers Med Sci. 2021 Winter;12:e72. doi: 10.34172/jlms.2021.72. Epub 2021 Dec 14. PMID: 35082987; PMCID: PMC8768015.
* Hamblin MR. Photobiomodulation in multiple sclerosis: a comprehensive review. J Biophotonics. 2022 Jan;15(1):e202100234. doi: 10.1002/jbio.202100234. Epub 2021 Nov 16. PMID: 34743202; PMCID: PMC8790072.
* Salti A, Alghabra G, Elgendy A, et al. Transcranial Photobiomodulation and Mitochondrial Health in Multiple Sclerosis. Cells. 2023 Aug 24;12(17):2150. doi: 10.3390/cells12172150. PMID: 37686121; PMCID: PMC10486001.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.